General Sessions
The Future of Health and Pharmacy Policy in the Second Trump Administration
Calusa Ballroom
A new administration and a new Congress will take root in Washington, D.C., as will new governors and legislators in state capitals. Who are the players who will live out the axiom that “people are policy,” and how will they affect the industry and America?
Steven C. Anderson, FASAE, CAE, IOM
President & CEO, National Association of Chain Drug Stores
Steven C. Anderson FASAE, CAE, IOM is President and Chief Executive Officer of the National Association of Chain Drug Stores (NACDS), a position he assumed in 2007. He represents and is the chief spokesperson for an industry that has annual sales of more than $1 trillion, employs more than 3.2 million individuals, and works with suppliers and other partners to help meet the health, wellness, and daily needs of patients and consumers across America. Nearly all Americans (91 percent), live within five miles of a retail pharmacy.
Jack Kalavritinos
Founder, JK Strategies
Jack Kalavritinos, a public affairs and health communications expert, has spent over 20 years working in senior corporate and association leadership and at the highest levels of government: the White House, HHS, DOL and the FDA. He serves on the APCO Worldwide International Advisory Committee, and the APCO Health Advisory Board.
Keith Nahigian
President, Nahigian Strategies
In 2000, Keith realized his vision for a multidimensional communications strategy firm that not only focused on the public relations needs for clients but also designed growth strategies for companies and organizations ranging from small start-up businesses and nonprofits to multinational corporations. A 27-year veteran with top-level experience advising, designing, and managing some of the largest campaigns in US history, Keith has worked for governors, members of Congress, and served in the White House.